Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

brand development

EISAI

Eisai establishes neuroscience unit in Belgium and Luxembourg

Follows the company's recent expansion in Australia

- PMLiVE

Biogen Idec appoints senior neuroscientists

Christopher Henderson and Richard Ransohoff make the move from academia

- PMLiVE

Interview: Mike Hutton, Lilly

Lilly’s chief scientific officer for neurodegenerative diseases talks about his hopes for Alzheimer’s research and making the move from academia to pharma

Bristol-Myers Squibb (BMS) building

BMS exits hep C, diabetes and neuroscience drug discovery

Will discontinue 'broad-based discovery work' in the therapy areas

- PMLiVE

The brand model – time for change?

Is it time to tune more into emotional decision-making, letting go of a strict formulaic approach?

- PMLiVE

The marketer’s role in early drug development

Why as a marketer you can do much to enable your R&D colleagues to find a product’s added value

Really? Another innovative product?

Is innovation really at the heart of what we offer, or has it simply become an ancient tradition?

- PMLiVE

The demise of stand-alone digital agencies?

Not a chance, says bmore creative's Ben Blackmore

- PMLiVE

New report points to demise of stand-alone digital agencies

85 per cent of marketing graduates believe social media and digital will integrate into full-service agencies

- PMLiVE

UCB signs research deal for novel neuroscience drugs

Partners with structural biology company ConfometRx

- PMLiVE

Building brand strength – Part 4

Commitment, responsiveness and protection – how far will Big Pharma go to preserve its brands?

EU funds ‘human brain’ computing project

Project could ultimately help develop personalised neurological treatments

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links